• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.08% Nasdaq Down0.35%

    More On BZYR



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Burzynski Research Institute, Inc. (BZYR)

    -Other OTC
    0.07 0.00(0.00%) Feb 8, 1:05PM EST
    ProfileGet Profile for:
    Burzynski Research Institute, Inc.
    9432 Katy Freeway
    Suite 200
    Houston, TX 77055
    United States - Map
    Phone: 713-335-5697
    Fax: 713-935-0649
    Website: http://www.burzynskiclinic.com

    Index Membership:N/A
    Industry:Diagnostic Substances
    Full Time Employees:1

    Business Summary 

    Burzynski Research Institute, Inc. operates a research and development facility of Antineoplaston drugs being tested for use in the treatment of cancer in the United States. The company focuses on the research, development, production, marketing, promotion, and sale of medical chemical compounds, such as growth-inhibiting peptides, amino acid derivatives, and organic acids. It also provides consulting services. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Burzynski Research Institute, Inc.

    Key Executives 
    Dr. Stanislaw R. Burzynski M.D., Ph.D., 73
    Chairman, Chief Exec. Officer, Pres, Principal Financial Officer and Chief Exec. Officer of Burzynski Clinic
    Mr. Patryk P. Goscianski M.B.A., 38
    Sec. and Treasurer
    Dr. Tomasz Janicki M.D., 50
    VP of Clinical Trials
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.